Clinical Trials Logo

Filter by:
NCT ID: NCT05882474 Completed - Clinical trials for COVID-19 Acute Respiratory Distress Syndrome

Correlation Between PaCO2 and Respiratory Effort in Patients With COVID-19 With Extracorporeal Membrane Oxygenation

Start date: December 1, 2022
Phase:
Study type: Observational

Excessive respiratory effort may cause self-inflicted lung injury (SILI) and inspiratory muscle injuries , stimulate desynchronization between the patient and ventilator , and worsen the perfusion of extrapulmonary organs . Appropriate respiratory drive and effort should be maintained during the treatment of patients with respiratory failure . In contrast, respiratory drive and effort are commonly increased in patients with COVID-19 pneumonia , and this phenomenon may persist in critically ill patients with COVID-19, even after receiving venovenous ECMO (vv-ECMO) support, owing to low pulmonary compliance and a high systemic inflammatory state . To reduce respiratory effort and drive, ICU physicians often administer high doses of sedative drugs, analgesics, and muscle relaxants. The prolonged use of high doses of these drugs can cause loss of the spontaneous cough reflex, which in turn impairs sputum drainage and eventually worsens pulmonary consolidation and lung infections. As the partial pressure of carbon dioxide in arterial blood (PaCO2) could affect the respiratory drive from the respiratory center (1), it has been shown that altering different levels of extracorporeal carbon dioxide removal in patients undergoing ECMO recovering from acute respiratory distress syndrome (ARDS) could alter respiratory drive. We hope to find a more appropriate target for maintaining PaCO2 to control respiratory effort in patients with COVID-19 undergoing ECMO.

NCT ID: NCT05882383 Completed - SARS-CoV-2 Clinical Trials

Changes of Optical Quality During the Peak of the Covid-19 Pandemic

Start date: November 25, 2022
Phase:
Study type: Observational

To explore whether cornea structure, and optical quality are affected by the covid-19 infection.

NCT ID: NCT05882370 Not yet recruiting - Clinical trials for Hepatocellular Carcinoma

TIPS Plus Cadonilimab in Advanced HCC With Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study

Start date: July 1, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) plus Cadonilimab (a PD-1/CTLA-4 bispecific antibody) in advanced hepatocellular carcinoma (BCLC-C Stage) accompanied by tumor thrombosis-associated portal hypertension.

NCT ID: NCT05882305 Active, not recruiting - Clinical trials for EBV-associated Lymphomas

KSD-101 Therapy for EBV-associated Lymphomas: an Exploratory Clinical Trial

Start date: June 10, 2023
Phase: Early Phase 1
Study type: Interventional

The main purpose of this study is to determine the tolerability and feasibility of KSD-101 in patients with EBV-associated haematologic neoplasms,to observe the characteristics of dose-limiting toxicity (DLT)and to explore the range of effective dose.

NCT ID: NCT05882214 Active, not recruiting - Hepatic Steatosis Clinical Trials

Metabolic Changes Induced by NMN in Healthy Subjects With Acute Binge Drink

NMN-MeABD
Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The goal of this double-blinded, randomized, crossover trial is to investigate the effects of NMN supplementation on liver function, liver fat content and lipid metabolism in healthy young subjects with acute binge drink. The main questions it aims to answer are: 1. if NMN administration could accelerate alcohol metabolism and alleviate hangover symptom; 2. if NMN administration could alleviate alcohol-induced liver injury and hepatic steatosis.

NCT ID: NCT05882110 Recruiting - Clinical trials for Autologous Epidermal Cell Transplantation

Amplification of Autologous Epidermal Cells to Repair Large Area Deep Wounds

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

Autologous epidermal cell transplantation is based on the principle and technology of skin tissue engineering, and is performed by cutting small pieces of autologous skin from patients, isolating and culturing and expanding them, and then transplanting them to the patient's wounds to repair the damage.

NCT ID: NCT05882058 Recruiting - Clinical trials for Small Cell Lung Carcinoma

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

Start date: September 25, 2023
Phase: Phase 2
Study type: Interventional

This study is open to adults with small cell lung cancer and other neuroendocrine tumours. The study is in people with advanced cancer for whom previous treatment was not successful or no standard treatment exists. The purpose of this study is to find a suitable dose of BI 764532 that people with advanced cancer can tolerate when taken alone. 2 different doses of BI 764532 are tested in this study. Another purpose is to check whether BI 764532 can make tumours shrink. BI 764532 is an antibody-like molecule (DLL3/CD3 bispecific) that may help the immune system fight cancer. Participants are put into 2 groups randomly, which means by chance. One group gets dose 1 of BI 764532 and the other group gets dose 2 of BI 764532. Participants get BI 764532 infusions into a vein when starting treatment. If there is benefit for the participants and if they can tolerate it, the treatment is given up to the maximum duration of the study. During this time, participants visit the study site regularly. The total number of visits depends on how they respond to and tolerate the treatment. The first study visits include an over-night stay to monitor participants' safety. Doctors record any unwanted effects and regularly check the general health of the participants.

NCT ID: NCT05882006 Recruiting - Clinical trials for Inflammatory Bowel Diseases

Gallstones and Risk of Inflammatory Bowel Disease

Start date: May 21, 2023
Phase:
Study type: Observational

The purpose of this study was to evaluate the association between gallstone disease and the risk of inflammatory bowel disease.

NCT ID: NCT05881967 Recruiting - Uterine Sarcoma Clinical Trials

Molecular Mechanism Study of Uterine Sarcoma

Start date: March 1, 2023
Phase:
Study type: Observational

The purpose of this project was to use multi-omics technology to screen the key factors for the occurrence and development of uterine sarcoma.

NCT ID: NCT05881837 Active, not recruiting - Clinical trials for Overweight or Obesity

Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes

Start date: June 13, 2023
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy and dose-response relationship of HRS9531 injection compared with placebo in reducing body weight in obese subjects without diabetes after 24 weeks of treatment.